Skip to Content


Main Content

Journal of Clinical Oncology | 2024

Minimal Residual Disease Status in Multiple Myeloma 1 year after autologous hematopoietic cell transplantation and lenalidomide maintenance are associated with long-term overall survival.

Pasquini M, Wallace PK, Logan B, Kaur M, Tario JD, Howard A, Zhang Y, Brunstein C, Efebera Y, Geller N, Giralt S, Hari P, Horowitz MM, Koreth J, Krishnan A, Landau H, Somlo G, Shah N, Stadtmauer E, Vogl DT, Vesole DH, McCarthy PL, Hahn T

PMID: 38701390

Related Articles

CIBMTR Study #: 0702